Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Finning reports Q4 and Annual 2023 results
-
TRREB: City of Toronto Mayor to Speak at TRREB Market Outlook and Year in Review Event
-
Gran Tierra Energy Inc. Announces Closing of an Additional $100 Million Aggregate Principal Amount of its 9.500% Senior Secured Amortizing Notes due 2029
-
Imperial Plans to Issue up to $45 Million of Non-Convertible Debentures
-
atai Life Sciences Appoints Anne Johnson as Chief Financial Officer
-
Range Announces Fourth Quarter Production and Pricing
-
CyberDoge Emerges as the Next Dogecoin – Skyrockets 300x in 72 Hours
-
Range Announces Proved Reserves
-
Hut 8 Operations Update for January 2024
-
Amlan International Partners with KOFARM to Showcase Gut Health Solutions for Swine at AMVECAJ 2024
-
NexImmune Announces Closing of $3.67 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
-
Weatherford Announces Fourth Quarter and Full Year 2023 Results
-
Oncternal Therapeutics to Participate in Oppenheimer 34th Annual Healthcare Life Sciences Conference
-
Midland States Bancorp Appoints Gerald Carlson to Board of Directors
-
BioSyent Declares First Quarter 2024 Dividend
-
Travis Barker Launches Barker Canna Co. with Hardware Partner Jupiter Research
-
Kernel Group Holdings, Inc. Announces Charter and Trust Agreement Amendments and Intention to Extend the Deadline to Complete a Business Combination to August 5, 2024
-
FutureFuel Corp. Declares Quarterly Cash Dividend Program for 2024
-
Key Tronic Corporation Announces Results for the Second Quarter of Fiscal Year 2024
-
Jamf announces immediate support for Apple Vision Pro, allowing customers to confidently and securely explore new ways of working
-
247Hire Awarded ClearlyRated’s Best of Staffing Award
-
O-I Glass Reports Full Year and Fourth Quarter 2023 Results
-
Transocean Ltd. Announces Fourth Quarter, Full Year 2023 Earnings Release Date
-
Genco Shipping & Trading Limited Announces Fourth Quarter 2023 Conference Call and Webcast
-
SiriusPoint Announces Date for Fourth Quarter and Full Year 2023 Earnings Release
-
HP Inc. Sets Annual Meeting and Record Dates
-
American Assets Trust, Inc. Reports Fourth Quarter and Year End 2023 Financial Results
-
CSW Industrials Deploys Over $30 Million, Executing on Acquisition Strategy in HVAC/R and Plumbing End Markets, With Focus on Indoor Air Quality
-
Genco Shipping & Trading Limited Announces Fourth Quarter 2023 Conference Call and Webcast
-
StoneX Group Inc. Reports Fiscal 2024 First Quarter Financial Results
-
Cingulate Announces Closing of $7.5 Million Public Offering
-
Midland States Bancorp, Inc. Increases Common Stock Cash Dividend to $0.31 Per Share and Declares Preferred Stock Dividend
-
Highwoods Announces Availability of Fourth Quarter and Full Year 2023 Results
-
Enact Reports Fourth Quarter and Full Year 2023 Results
-
Apollo Commercial Real Estate Finance, Inc. Reports Fourth Quarter 2023 Results
-
DHT Holdings, Inc. Fourth Quarter 2023 Results
-
Arbor Realty Trust Schedules Fourth Quarter 2023 Earnings Conference Call
-
Evolution Petroleum Reports Second Quarter Fiscal 2024 Results and Declares Quarterly Cash Dividend for the Fiscal 2024 Third Quarter
-
H&R Block Reports Fiscal 2024 Second Quarter Results; Full Year Outlook Reaffirmed
-
GAMCO Investors, Inc. Reports Results for the Fourth Quarter and Year Ended December 31, 2023
-
Array Technologies, Inc. Announces Fourth Quarter and Full Year 2023 Earnings Release Date and Conference Call
-
Freshworks Reports Fourth Quarter and Full Year 2023 Results
-
Viracta Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
-
Corvus Pharmaceuticals Appoints Jeffrey Arcara as Chief Business Officer
-
Gencor Releases First Quarter Fiscal 2024 Results
-
Enphase Energy Reports Financial Results for the Fourth Quarter of 2023
-
H&R Block Chief Financial Officer Tony Bowen Announces Retirement
-
Madrigal Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
-
Sutro Biopharma to Participate in Upcoming Investor Conferences
-
Ventyx Biosciences to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference


